化学療法による悪心·嘔吐に対するオランザピンの効果
スポンサーリンク
概要
- 論文の詳細を見る
Nausea and vomiting due to chemotherapy not only reduce quality of life but also cause suspension or extension of therapy,or reductions in the dosages of agents used,and influence therapeutic effects.Their control is therefore extremely important.In Olanzapine,one of the multi-acting receptor-targeted antipsychotics,which produce an antimetic effect by acting as an antagonist against multiple receptors related to the mechanism of nausea and vomiting,could be effective in this regard.It is mentioned in the guidelines of the National Comprehensive Cancer Network.In the present study,for patients who developed nausea and vomiting in the initial course of chemotherapy,Olanzapine was administered at 2.5 mg/day from the day prior to the 2 nd course of chemotherapy for 7 days.A comparison of acute and delayed nausea and vomiting symptoms between the initial and 2 nd courses of chemotherapy showed that Olanzapine had no additional effect against acute symptoms but for delayed symptoms,there was a significant improvement in the severity and period of nausea and vomiting.In the future,it will be necessary to accumulate data for many cases in order examine the safety of Olanzapine and dosages for it.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)